Latest Kaiser Health News Stories
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
One out of every 13 seniors in America struggles to get enough food to eat while the federal program intended to help hasn’t kept pace with the graying population. KHN Midwest editor/correspondent Laura Ungar explains what you need to know about this largely hidden problem.
In the background, advisers weigh the risks of rolling out a comprehensive health care proposal. Peering into the crystal ball, here’s a glimpse of what could be included in the GOP plan.
One out of every 13 older Americans struggles to find enough food to eat while the federal program intended to help hasn’t kept pace with the graying population.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
The tax on generous health plans — originally envisioned as a way to help pay for the ACA and change consumers’ behavior — has never been implemented, and Congress is considering repeal.
You asked about drug prices, the “Cadillac tax” on generous insurance plans and why Americans don’t know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN’s Julie Rovner to answer those questions.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
A case of questionable logic.
Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
The drug industry has the biggest lobbying war chest.
Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.